Camellia. API struggles with competition

Australian Pharmaceutical Industries, based at Camellia, is battling several difficulties including lower retail spending and increasing competition in wholesaling and the health and beauty sector. API CEO, Stephen Roche, said in The Australian Financial Review, the company will adapt to the changing industry landscape in order to protect margins.